Agoracom Blog Home

Posts Tagged ‘Marijuana’

« Older Entries
Newer Entries »

INTERVIEW: As Cannabis Companies Struggle, $MOTA.ca Delivers $29M Revenue, $3.6M EBITDA – And That’s Just The Start $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 4:03 PM on Monday, February 24th, 2020

In 1948, Winston Churchill said, “Those who fail to learn from history are condemned to repeat it”.  Unfortunately, many Cannabis companies aren’t historians and are repeating the dot-com to dot-bomb cycle of raising tons of money but no clue how to build a real business with it.

You know what else we learned from that cycle?  Web 2.0 was the birth of companies with real business plans, products, customers and revenues.  They went on to dominate the next 20 years.

Enter MOTA Ventures (MOTA:CSE), who has become a leader in online CBD sales into the North American market, thanks to an e-commerce “engine” built by CEO Ryan Hoggan and his team over the past few years at Unified Funding.  That engine is so powerful that is has racked up over $200 MILLION in sales from over 1 million paying customers over a number of products, including CBD sales of $25 MILLION by “First Class CBD”, which was acquired by MOTA for $32 MILLION.

As the new CEO of MOTA, Ryan is bringing that ecommerce engine into the Company to further drive CBD sales into the US market, as well as, Europe.  As an online company ourselves, we can pretty easily spot companies that are just trying to piggy back “e-commerce”.  Ryan is the real deal.  As you will hear in this interview, he has already achieved monster e-commerce success with the likes of Boeing, Daimler and the Lakers basketball team on over 100 health and wellness products.

The best part for MOTA shareholders?  Ryan is highly motivated to continue with his successful ways because Unified Funding can earn an additional $15 MILLION if First Class CBD achieves sales of $62 MILLION.  In my experience, companies don’t put bonuses into contracts unless they both believe there is a reasonable belief they can be achieved. Will he hit $62M?  Or fall short at the other 2 milestones of $52M and $42M?

Watch this interview and you be the judge.  Either way, MOTA shareholders should get their popcorn ready because Ryan has already proven he’s leading MOTA into the Cannabis 2.0 phase.  Success is already here, now its just a question of how high MOTA will fly.

Watch this interview and share it with every investor you know!

Tags: , , , , , ,
Posted in AGORACOM Via Satellite, All Recent Posts, Featured, Mota Ventures Corp. | Comments Off on INTERVIEW: As Cannabis Companies Struggle, $MOTA.ca Delivers $29M Revenue, $3.6M EBITDA – And That’s Just The Start $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

North Bud Farms $NBUD.ca Announces the Appointment of Jeffrey Stoss as Chief Financial Officer $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 9:15 AM on Monday, February 24th, 2020
  • Announced the appointment of Jeffrey Stoss as Chief Financial Officer of the Company.
  • Mr. Stoss brings more than 17 years of finance experience to his role at NORTHBUD, with a particular specialty in high-growth environments.

TORONTO, Feb. 24, 2020 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company“) is pleased to announce the appointment of Jeffrey Stoss as Chief Financial Officer of the Company.

“We are pleased to welcome Jeff to our dynamic team as NORTHBUD is at an exciting time in its development,” stated Sean Homuth, CEO of North Bud Farms Inc. “Jeff brings specialty experience in accounting and finance having worked with and advised many public companies over the years in both Canada and the United States. His leadership and expertise will be essential in executing our strategic plan and taking the Company to its next level of growth.”

Mr. Stoss brings more than 17 years of finance experience to his role at NORTHBUD, with a particular specialty in high-growth environments. He is the co-founder and Chief Operating Officer of the outsourced finance services firm, Positive Venture Group Inc.  He has previously served as CFO for publicly-traded companies and technology start-ups. Mr. Stoss has professional accountant designations in both Canada and the United States.

RSU Grants

On February 20, 2020, the Company’s board of directors approved the grant of 361,000 restricted share units (“RSUs”) to certain directors and consultants of the Company. The RSUs vest in four equal tranches starting three months from the date of grant. Each vested RSU entitles the holder thereof to receive one common share of the Company upon delivery of an exercise notice, in accordance with the Omnibus Plan.
   
About North Bud Farms Inc.

NORTHBUD, through its U.S. subsidiary Bonfire Brands USA, has acquired cannabis production facilities in California and Nevada. The Salinas, California 11-acre farm is actively cultivating cannabis in its 60,000 sq. ft. of licensed greenhouse production space. The Reno, Nevada property is located on 3.2 acres of land which was acquired through the acquisition of Nevada Botanical Science, Inc., a world class cannabis production, research and development facility with 5,000 sq. ft. of indoor cultivation which holds medical and adult use licenses for cultivation, extraction and distribution. Through its wholly-owned Canadian subsidiary, GrowPros MMP Inc., the Company is pursuing a license under The Cannabis Act, to cultivate in its state-of-the-art purpose-built cannabis production facility located on 135 acres of agricultural land in Low, Quebec, Canada.

For more information visit: www.northbud.com

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements and information included in this press release that, to the extent they are not historical fact, constitute forward-looking information or statements (collectively, “forward-looking statements”) within the meaning of applicable securities legislation.  Forward-looking statements, include but are not limited to those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management.

Forward-looking statements, including those regarding the success of the Company’s licence application, the Company’s ability to execute its strategic plan, conditions in the cannabis market, the Company entering agreements in connection with the B2B supply of cannabis and the Company’s transition into a revenue-generating operational phase of development are based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements.  Such risks and uncertainties include, among others, the risk factors included in the Company’s final long form prospectus dated August 21, 2018, which is available under the Company’s SEDAR profile at www.sedar.com. Accordingly, readers should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statements to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected] 

Tags: , , , , ,
Posted in North Bud Farms Inc | Comments Off on North Bud Farms $NBUD.ca Announces the Appointment of Jeffrey Stoss as Chief Financial Officer $CGC $ACB $APH $CRON.ca $OGI.ca

Mota Ventures $MOTA.ca Announces Transition After Definitive Close of First Class #CBD Acquisition; Ryan Hoggan is New CEO $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 7:34 AM on Saturday, February 22nd, 2020
  • Announced a transition after the definitive close of First Class CBD acquisition
  • Appointed Ryan Dean Hoggan to Chief Executive Officer
  • Acquisition of First Class CBD coupled with the upcoming U.S. roll out of the Company’s European CBD brand, Sativida, made the appointment of Mr. Hoggan to Chief Executive Officer a natural fit
  • Mr. Hoggan brings more than 18 years of leadership, global business development and entrepreneurship experience in the health equipment, medical devices and natural health products sectors

VANCOUVER, BC / February 22, 2020 / Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ:GR)(OTC:PEMTF) (the “Company” or “Mota“) is pleased to announce a transition after the definitive close of First Class CBD acquisition, the Company’s Board of Directors has appointed Ryan Dean Hoggan to Chief Executive Officer. The acquisition of First Class CBD coupled with the upcoming U.S. roll out of the Company’s European CBD brand, Sativida, made the appointment of Mr. Hoggan to Chief Executive Officer a natural fit. Ryan brings a wealth of expertise to this role, being one of the founders of Unified Funding LLC and First Class CBD. Ryan is an experienced strategist, with a strong understanding of building high value consumer brands with significant annual revenue. Ryan’s extensive background in the online e-commerce space will continue to drive the Company’s rapid growth in the US and spearhead its expansion into the European market. The Company intends to continue its roll up strategy of acquiring profitable, well-known CBD brands globally.

Mr. Hoggan brings more than 18 years of leadership, global business development and entrepreneurship experience in the health equipment, medical devices and natural health products sectors. Early in his career, Ryan took on a leadership role in his family business, HOGGAN Health Industries, where he led operations, business development and marketing efforts. After identifying an untapped niche in the market, he founded Hoggan Medical where he went on to launch over 100 health, fitness and medical device products and negotiated contracts with big and small customers including the Mayo Clinic, Boeing, Daimler AG and the Los Angeles Lakers (NBA).

In 2014, Ryan discovered the power of CBD and essential oils – both personally and professionally – after a personal health scare prompted him to research and subsequently try holistic products to improve his health. The experience ultimately led him to become a Partner and President of Offer Space, LLC and Real Oil, LLC, two rapidly growing E-commerce and technology companies focused on serving U.S. based and international consumers in the CBD and natural health products market. In June 2019, Mr. Hoggan led a strategic divestiture of the businesses to Unified Funding, LLC to help continue an impressive growth trend. Through the operations of Unified Funding, LLC, the business has generated a database of over 4.5 million customer records and facilitated over $200 million in consumer transactions from more than one million paying customers in sectors such as beauty, nutrition and CBD products.

Mr. Hoggan holds a Bachelor of Business Administration (BBA) from Westminster College, an MBA from The University of Arizona and a Master of Global Management (MGM) from the Thunderbird School of Global Management at Arizona State University.

In connection with Ryan’s appointment to CEO, Joel Shacker will transition to the role of President of the Company and will remain a member of the board of directors.

“I am very excited to take on the CEO role at Mota and focus the operations on becoming a global E-commerce CBD company. I am also excited about the partnership between Unified and Sativida. Unified’s extensive experience in the U.S. and strong logistics and supply chain will provide significant support for the launch of the Sativida line in the U.S. I believe through the direct-to-consumer online platforms we will become a leader in the CBD space. We plan to aggressively expand First Class’s existing operations in the U.S. as well as launch a European expansion, which we anticipate will yield similar results to our U.S. operations last year,” stated Ryan Hoggan, CEO of the Company.

“We are extremely happy to have someone with Ryan’s extensive experience stepping into this role. I am confident in his ability to execute on expanding operations and generating further revenue. I look forward to continuing to build the Company in my new role as President and to working with Ryan during his transition to CEO of Mota.” stated Joel Shacker.

About Mota Ventures Corp.

Mota is seeking to become a vertically integrated global CBD brand. Its plan is to cultivate and extract CBD into high-quality value-added products from its Latin American operations and distribute it both domestically and internationally. Its existing operations in Colombia consist of a 2.5-hectare site that has optimal year-round growing conditions and access to all necessary infrastructure. Mota is looking to establish sales channels and a distribution network internationally through the acquisition of the Sativida and First Class CBD brands. Low cost production, coupled with international, direct to customer sales channels will provide the foundation for the success of Mota.

ON BEHALF OF THE BOARD OF DIRECTORS

MOTA VENTURES CORP.
Joel Shacker

President

For further information, readers are encouraged to contact Joel Shacker, President & CEO at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statement

All statements in this press release, other than statements of historical fact, are “forward-looking information” with respect to the Company within the meaning of applicable securities laws, including with respect to the Company’s rapid growth in the US and expansion into the European market, its plans to become a vertically integrated global CBD brand, its plans to cultivate and extract cannabis to produce CBD and high-quality value added CBD products in Latin America for distribution domestically and internationally and its plans to acquire revenue-producing CBD brands and operations in Europe and North America. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited those identified and reported in the Company’s public filings under the Company’s SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.

SOURCE: Mota Ventures Corp.

Tags: , , , , , , ,
Posted in Featured, Mota Ventures Corp. | Comments Off on Mota Ventures $MOTA.ca Announces Transition After Definitive Close of First Class #CBD Acquisition; Ryan Hoggan is New CEO $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

Empower Clinics $CBDT.ca – #Cannabis Extraction Stocks Best Profit Play for #Marijuana Investors $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 5:44 PM on Wednesday, February 19th, 2020

SPONSOR:

Why Empower Clinics

  • A leading owner/operator of physician staffed health and pain management clinics.
  • Patient database of over 165,000 patients 
  • Platform generating $1.4M USD (9 months ending Sept. 30, 2019)
  • Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
  • Recently launched CBD extraction facility
  • First extraction system capacity = 2,300 Kg per year.
  • CBD based products are poised to be a $20B global industry by 2022
  • Medical cannabis is poised to be a $100B global industry by 2025

Cannabis Extraction Stocks Best Profit Play for Marijuana Investors

Cannabis Extraction Stocks on Pace for Massive Growth

  • Cannabis extraction companies are at the center of the hottest trend to hit the legal cannabis industry in years: marijuana derivatives
  • Those include cannabis-infused products like edibles, vapes, concentrates, beverages, tinctures, and topicals.

By John Whitefoot, BA

In the lead-up to the October 2018 legalization of recreational cannabis in Canada, all eyes were on marijuana growers. It made sense. They were the companies that were going to supply the industry with dried flower. And demand for weed was expected to go through the roof.

While 2019 was a tough year for some pot stocks, 2020 is shaping up to be much better. Not all pot stocks are created equal though. One area that looks like it’s poised to outstrip the broader weed stock market is cannabis extraction stocks.

In 2019, global pot sales soared 48% year-over-year to $15.0 billion. In 2020, marijuana sales are expected to climb 38%. By 2024, global weed sales are projected to top $43.0 billion.  (Source: “Global Cannabis Sales Grow 48% to $15 Billion in 2019,” BDS Analytics, January 16, 2020.)

A compound annual growth rate of 23% is pretty hard to dismiss.

Legal marijuana is a young industry that is providing investors with a lot of choices. In addition to the marijuana producers, there are companies that serve or support those producers—with elements such as hydroponics, processing, extraction, financing, set-up, e-commerce, and operating dispensaries.

So far they have mostly been serving the relatively small Canadian market (Canada has a population less than that of California)—one that, as of September 2019, had yet to generate $1.0 billion in annual legal pot sales. (Source: “The Retail Cannabis Market in Canada: A Portrait of the First Year,” Statistics Canada, Statistics Canada, December 11, 2019.)

That number will likely jump considerably once the Canadian marijuana market matures. Investors who do not want to wait for that to happen, however, might want to consider cannabis extraction stocks.

Why? Cannabis extraction companies are at the center of the hottest trend to hit the legal cannabis industry in years: marijuana derivatives. Those include cannabis-infused products like edibles, vapes, concentrates, beverages, tinctures, and topicals.

Cannabis-Infused Products Are Crucial for the Pot Industry

Cannabis-infused products are opening up a whole new revenue stream for the legal marijuana industry. That’s because these items are being introduced to consumers who may have been reluctant to try traditional cannabis products. Some people like the buzz or the medicinal properties but don’t want to inhale smoke.

A few years ago, in the U.S., roughly 75% of the marijuana market was taken up by cannabis flower. Today that number is around 40%. A similar trend has been happening in Canada. (Source: “Why Business Is Booming for Cannabis Extraction Companies Despite the Supply Shortage,” Financial Post, April 19, 2019.)

That is a godsend for marijuana companies looking to juice their top and bottom lines. That’s because cannabis-infused products have higher margins than traditional dried cannabis does.

Providing products that have high demand and a high profit margin is a no-brainer.

Cannabis Extract Industry Will Be Huge

In January 2020, cannabis-infused products legally hit store shelves in Canada for the first time. That came just a year after the Canadian government approved the sale of recreational marijuana in the form of dried flower, oils, and sprays.

The cannabis extraction industry will be massive, because the sales projections for pot-infused products are huge.

According to one study, the total legal marijuana market in Canada will reach $11.0 billion by 2025. Of that, 54% is expected to come from sales of edibles and other cannabis-extract products. (Source: “One-in-five Canadians will consume cannabis in 2025: Ernst & Young,” Yahoo! Finance Canada, March 26, 2019.)

And that’s just for Canada; the global market for cannabis derivatives is expected to nearly double over the next five or six years to $194.0 billion. (Source: “Canada’s consumer market for edibles estimated to reach at least $1.6 billion annually: Deloitte,” The GrowthOp, June 3, 2019.)

Now, many cannabis companies do not have in-house extraction facilities. To make marijuana-infused products, they need to outsource the work. That’s where cannabis extraction companies come into play.

Instead of growing marijuana, they take hemp and cannabis biomass and process it for the resins, concentrates, distillates, and targeted cannabinoids.

Admittedly, some of the bigger licensed marijuana growers in Canada already have—or are constructing—their own extraction facilities, but it won’t be enough to meet the future demand for cannabis oils.

In fact, some cannabis growers have signed multi-year, renewable extraction agreements with the bigger cannabis extraction companies in Canada.

Analyst Take

Cannabis extraction stocks could be a huge profit opportunity for marijuana investors. Marijuana-infused products became legal in Canada at the start of 2020, and the industry is expected to experience double-digit growth over the coming years.

Thanks to higher margins, more and more companies are looking to produce cannabis-infused products. If marijuana-derivative products sell well, cannabis extract stocks should rise in value.

Source: https://www.profitconfidential.com/marijuana/cannabis-extraction-stocks-best-profit-play-marijuana-investors/

Tags: , , , ,
Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca – #Cannabis Extraction Stocks Best Profit Play for #Marijuana Investors $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

North Bud Farms $NBUD.ca Announces Name Change and Provides U.S. Update $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 9:39 AM on Wednesday, February 19th, 2020
  • Harvested approximately 400 lbs of various grades and strains of cannabis
  • Received a California state processing licence in addition to the existing five cultivation, extraction and distribution licenses it acquired from the Qlora Group in 2019
  • Harvested 40 lbs of high-grade cannabis testing at approximately 20% THC in Reno

TORONTO, Feb. 19, 2020 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company“) is pleased to provide shareholders with an update on our U.S. operations, Bonfire Brands USA (“Bonfire”).

Salinas, California

To date, the Company has harvested approximately 400 lbs of various grades and strains of cannabis. As anticipated, the winter season yields were moderate with large flowers testing at approximately 19% THC. The Company has sold approximately 50% of the harvest in wholesale quantities. The Company expects its next harvest in 60 days and is looking for an incremental increase in quality and yield. The Company will provide revenue updates at the end of the quarter.

Licensing

The Company is pleased to announce it has received a California state processing licence in addition to the existing five cultivation, extraction and distribution licenses it acquired from the Qlora Group in 2019. This new licence will allow the Company to process, package and distribute cannabis and cannabis products acquired from other licensed producers in the state on a pay per use basis.

“Maximizing revenue streams in California where established and highly regulated retail and distribution models exist has required new entrants to operate within all verticals,” said Justin Braune, President, Bonfire Brands USA. “This strategy requires significant capital expenditures and has historically proven very difficult to execute. By leveraging our strategic infrastructure into agreements with established operators, Bonfire expects to increase revenue streams and achieve profitability quicker with lower capital expenditure risks.”

“I am very pleased by the significant progress made by our California team in their short time since we completed the acquisition of the Qlora Group,” said Sean Homuth, CEO of NORTHBUD. “In an industry that has seen companies struggle to manage high infrastructure costs while navigating ever evolving distribution landscapes, the anticipated revenue from this model will be very crucial for the Company as we move towards achieving EBITDA positive operations.”
   
Reno, Nevada

To date, the Company has harvested 40 lbs of high-grade cannabis testing at approximately 20% THC. This product is being sold under the NORTHBUD brand to select retailers in Reno and Las Vegas and represents the first revenue in Nevada for Bonfire Brands.  The Company will update the market further at the end of the quarter.

The Company has begun construction of two additional cultivation and processing rooms which will increase annual revenue capacity by 40%. With recent cost cutting measures implemented post acquisition, the Company believes it is on track to bring the Nevada operation to cash flow positive in the first quarter of 2020.     

The Company has entered into a third-party service agreement with LTH Logistics (“LTH”), a licensed third-party distribution and delivery company. As per the terms of the agreement, LTH will provide these third-party services under the distribution licence of Nevada Botanical Sciences with revenue generated being split 60/40 in favor of Bonfire Brands USA.

“Similar to California, many Nevada licensees have been operating across all verticals,” said Justin Braune, President, Bonfire Brands USA. “Bonfire has chosen to reduce execution risk and minimize capital expenditures by working with established operators who seek to benefit from our strategic infrastructure, which will allow the company will expedite its progression towards EBITDA positive operations.”  

Corporate Name Change

As approved at our recent annual shareholder meeting, the Company will officially change its name to Bonfire Holdings Inc. The Company has reserved and will begin trading under the ticker symbol BURN in the near future. The Company believes this better represents the vision and structure of the Company moving forward.  The Company owns brands such as NORTHBUD, California Bud Co., Live For The Day (LFTD) and Trichomic and manufactures and distributes Happiest Hour beverages in the state of Nevada.  

About North Bud Farms Inc.

North Bud Farms Inc., through its U.S. subsidiary Bonfire Brands USA, has acquired cannabis production facilities in California and in Nevada. The Salinas, California 11-acre farm is actively cultivating cannabis in its 60,000 sq. ft. of licensed greenhouse production space. The Reno, Nevada property is located on 3.2 acres of land which was acquired through the acquisition of Nevada Botanical Science, Inc. a world class cannabis production, research and development facility with 5,000 sq. ft. of indoor cultivation which holds medical and adult use licenses for cultivation, extraction and distribution. Through its wholly owned Canadian subsidiary, GrowPros MMP Inc., the Company is pursuing a licence under The Cannabis Act, to cultivate in its state-of-the-art purpose-built cannabis production facility located on 135 acres of Agricultural Land in Low, Quebec, Canada.

For more information visit: www.northbud.com

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including but not limited to those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. Forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward-looking statements that include, but are not limited to, statements relating to the Company’s California, Nevada operations and its corporate name change to Bonfire Holdings Inc. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Such risks and uncertainties include, among others, the risk factors included in the Company’s final long form prospectus dated August 21, 2018, which is available under the Company’s SEDAR profile at www.sedar.com. 

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

Tags: , , , , , ,
Posted in All Recent Posts, North Bud Farms Inc | Comments Off on North Bud Farms $NBUD.ca Announces Name Change and Provides U.S. Update $CGC $ACB $APH $CRON.ca $OGI.ca

Empower Clinics $CBDT.ca Launches Improved Line of #CBD Products and Confirms 2020 Hemp Handlers License for Extraction Facility in Oregon $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 7:04 AM on Wednesday, February 19th, 2020

Empowers’ CBD product line Sollievo has been reformulated to include 900mg of CBD

  • Launched a series of re-formulated versions of it’s CBD tincture product line SOLLIEVO. Italian for Relief.
  • New formulated Sollievo is non-GMO, non-psychoactive, has rapid bioavailability and is sourced from USA grown hemp.

VANCOUVER BC / February 19, 2020 / EMPOWER CLINICS INC. (CSE: CBDT) (OTC: EPWCF) (Frankfurt 8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented CBD life sciences company is pleased to announce it has launched a series of re-formulated versions of it’s CBD tincture product line SOLLIEVO. Italian for Relief.

The new formulated Sollievo is non-GMO, non-psychoactive, has rapid bioavailability and is sourced from USA grown hemp. The products are all third-party lab tested for quality, and the new terpene profiles for each of the four tincture categories of Chronic Pain, Digestion, Insomnia and Anxiety, are aimed to promote mind and body wellness.

“We have spent the last few months dramatically increasing the potency, flavour profiles, and profitability of the Sollievo tincture product lines”, said Dustin Klein, SVP Business Development and Director, Empower Clinics Inc. “Our new formulations were manufactured in a state-of-the-art CGMP facility, ensuring quality and consistency, and by tripling the amount of CBD per unit to 900mg, it provides a more potent single dose to our customers, to our patients.”

The new Sollievo tincture lines are now available in the Sun Valley Health wellness clinics, are available online and will be a standard product offering in the Sun Valley Health franchise locations.

The Company also announces it has been awarded its 2020 Oregon Department of Agriculture hemp handlers license, ensuring that the new Sandy, OR extraction and production facility is compliant and licensed to operate under the regulatory framework of the State.

“I’m excited to have our new Sollievo tinctures available for purchase, and so proud of Dustin and our team who have brought an exemplary product to market.” said Steven McAuley, Chairman & CEO of Empower. “Having the hemp handlers license in place for 2020 and continuing toward the close of our Heritage Cannabis joint venture, allows us to control our supply chain and to bring best-in-class CBD products to domestic and international markets.”

The Company also advises that Mat Lee’s position as CFO has concluded and we thank Mat for his contributions. The Company continues to be supported by Invictus Accounting and its team of specialists, who have been integral to creating financial and accounting controls that allow us to report quarterly results well in advance of requirements. The Company has commenced a search for a new Chief Financial Officer.

ABOUT EMPOWER

Empower is a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company produces its proprietary line of cannabidiol (CBD) based products and distributes products through company owned and franchised clinics, with wholesale partnerships, online channels and with new retail opportunities nationwide in the U.S. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Steven McAuley
Chairman & CEO
[email protected]
604-789-2146

Investors: Dustin Klein
SVP, Business Development
[email protected]
720-352-1398

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE: Empower Clinics Inc.

Tags: , , , , ,
Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca Launches Improved Line of #CBD Products and Confirms 2020 Hemp Handlers License for Extraction Facility in Oregon $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

North Bud Farms $NBUD.ca Provides a Corporate Update – Company Is Now Awaiting The Issuance of Its Standard Cultivation License $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 8:53 AM on Friday, February 14th, 2020

Status of Cultivation Licence Application for Cannabis Production Facility in Low, Quebec

  • Company is pleased to update shareholders that it has addressed outstanding issue and has provided Health Canada with the required information requested. The Company is now awaiting the issuance of its standard cultivation license.

TORONTO, Feb. 14, 2020 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company“) provides shareholders with the following corporate update:

Status of Cultivation License Application for Cannabis Production Facility in Low, Quebec

As previously announced, the Company was informed on a conference call with the regulators in late January of one outstanding item that was required before the Company could be issued its cultivation licence. The Company is pleased to update shareholders that it has addressed this outstanding issue and has provided Health Canada with the required information requested. The Company is now awaiting the issuance of its standard cultivation licence.

Board of Directors Change

Dr. Teresa DeLuca has advised the Company of her desire to step down from the Board of Directors effective immediately in order to focus on her other professional obligations. 

“Dr. DeLuca served on the Board since the Company’s initial listing in 2018 and we would like to thank her for her service and wish her well in her future endeavors,” said Ryan Brown, Executive Chairman of NORTHBUD. 

About North Bud Farms Inc.
North Bud Farms Inc., through its U.S. subsidiary Bonfire Brands USA, has acquired cannabis production facilities in California and in Nevada. The Salinas, California 11-acre farm is actively cultivating cannabis in its 60,000 sq. ft. of licensed greenhouse production space. The Reno, Nevada property is located on 3.2-acres of land which was acquired through the acquisition of Nevada Botanical Science, Inc. a world class cannabis production, research and development facility with 5,000 sq. ft. of indoor cultivation which holds medical and adult use licenses for cultivation, extraction and distribution. Through its wholly owned Canadian subsidiary, GrowPros MMP Inc., the company is pursuing a license under The Cannabis Act, to cultivate in its state-of-the-art purpose-built cannabis production facility located on 135-acres of Agricultural Land in Low, Quebec, Canada.

For more information visit: www.northbud.com

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements and information included in this press release that, to the extent they are not historical fact, constitute forward-looking information or statements (collectively, “forward-looking statements”) within the meaning of applicable securities legislation.  Forward-looking statements, including, but not limited to, those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management.

Forward-looking statements, including, but not limited to, those regarding the success of the Company’s licence application in Quebec and the Company’s transition into a revenue generating operational phase of development are based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the risk factors included in the Company’s final long form prospectus dated August 21, 2018, which is available under the Company’s SEDAR profile at www.sedar.com. Accordingly, readers should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statements to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

Tags: , , , , , , ,
Posted in North Bud Farms Inc | Comments Off on North Bud Farms $NBUD.ca Provides a Corporate Update – Company Is Now Awaiting The Issuance of Its Standard Cultivation License $CGC $ACB $APH $CRON.ca $OGI.ca

INTERVIEW: Empower $CBDT.ca Signs Exclusive Content Deal To Further Convert Its’ Database Of 165,000 Patients $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 5:57 PM on Thursday, February 13th, 2020

With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would kill for.  Add in the fact patient visits increased 351% in Q4 and it becomes the kind of company small cap investors have been dying to find as they watch pretender companies melt away.

But it doesn’t end there.

CBD extraction has been a key element of the company’s vertical integration. Producing its’ own hemp-derived CBD products for its own massive patient list just makes sense. However, thanks to an LOI (moving towards definitive agreement) to JV with extraction experts Heritage Cannabis, the Company’s 5,000 sq ft facility in Oregon is also planning to serve big brand 3rd party partners in the USA .  Empower brings the infrastructure, Heritage brings the expertise and balance sheet.  The result is a match made in shareholder heaven with initial annual capacity of 6,000 Kg at ~ $US 5,000 per Kg, which adds up to $US 30,000,000 in potential revenue.

But It Doesn’t End There

The Company’s CEO, Steven McAuley is Six Sigma certified under the quality initiative of legendary GE chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the Canadian small cap markets. Never …. which also explains how McAuley has brought Empower so far in just 11 months.

If anyone understands digital, it’s McAuley. So it should come as no surprise the Company just signed an exclusive multi-year, multi-national licensing deal with EuroLife to license its “Cannvas.me” cloud based online education platform for the US and Mexico.  Amongst other things, Empower plans to integrate the education platform into its clinics across the United States to help further convert their 165,000 patient database to CBD and medical cannabis through proper education.  

The site also contains premium content for physicians who need to educate themselves and comes with millions of page views already, as well as, 15,000 opted in subscribers, which explains the $460,000 in licensing over 3 years – but $210,000 of that is Empower stock priced at $0.10 (125% above current market prices, which gives you an idea of the confidence EuroLife principals have in the future of Empower.

P.S.  The interview takes place from the floor of the Arizona Cannabis Expo, where Empower has multiple booths and an actual pop-up clinic to acquire new customers in real-time.  That’s what happens when you have a company run by a Six Sigma Certified CEO.

Grab your favourite beverage and settle in to watch what may be your next great small cap investment.

Tags: , , , , , ,
Posted in AGORACOM Via Satellite, All Recent Posts, Empower Clinics Inc., Featured | Comments Off on INTERVIEW: Empower $CBDT.ca Signs Exclusive Content Deal To Further Convert Its’ Database Of 165,000 Patients $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Empower $CBDT.ca Signs Multi-Year Multi-National Licensing Deal with EuroLife $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 4:18 PM on Thursday, February 13th, 2020
  • Empower Clinics to license online education technology to provide strategic value to their patients, retail locations, and to their expanding network of franchisees.

VANCOUVER BC / February 13, 2020 / EMPOWER CLINICS INC. (CSE:CBDT)(OTC:EPWCF)(Frankfurt:8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented CBD life sciences company is pleased to announce it has signed a letter of intent (the “LOI”) with EuroLife Brands Inc. (EURO) (3CMA) (EURPF) (“EuroLife”), a vertically integrated enterprise focused on the pan-European hemp, cannabinoid, and health and wellness sector, granting Empower an exclusive license of EURO’s “Cannvas.me” cloud based online educational platform in certain jurisdictions. The education technology is to be accessed by employees of Empower’s owned and franchised clinics, patients, and a network of nationwide retailers in the United States.

Under the terms of the LOI, Empower will be granted an exclusive license of the Cannvas.me platform in the United States and Mexico (expandable to other jurisdictions). It is envisioned that Empower will integrate and leverage the robust Cannvas.me platform with its burgeoning clinic network across the continental United States. The LOI contemplates a three-year term with a three-year renewable option. An annual $70,000.00 CAD licensing fee will be paid for the life of the proposed agreement, and the issuance of $250,000.00 CAD of Empower common stock at a price of $0.10 per share.

“This next phase in our partnership with Euro is the culmination of many months of collaboration to create access to the immense amount of educational content on the Cannvas.me platform.” said Steven McAuley, Chairman & CEO of Empower. “Empower, as thought leaders in the medical cannabis sector, need to lead consumer & physician education providing a branded curated experience starting with our 165,000 patients and then extending through our network of corporate and franchised clinics.”

“EuroLife’s SaaS based education technology platform will allow Empower Clinics to educate a consumer, retailer, and medical patient on an incredibly efficient basis,” said Shawn Moniz, Chief Executive Officer, EuroLife Brands Inc. “We look forward to working with Empower and their expanding clinic network in providing unencumbered access to our online technology solution.”

In 2018 EuroLife launched a consumer education portal for medical and recreational cannabis consumers. Through many discussions with industry stakeholders the management team discovered there was significant demand for a cloud-based education portal for licensed producers, retail dispensaries and other large to mid-sized companies in the cannabis sector. Executing on a renewed B2B technology model EuroLife recently delivered a redesigned budtender education portal for Aphria Inc. (see February 4, 2020 news release), the global cannabis leader with an unrelenting commitment to people, product quality and innovation. The portal allows Aphria to ensure retail employees across Canada are well-versed in Aphria’s line-up of adult-use brands and enabled with information to provide superior customer service.

ABOUT EMPOWER

Empower is a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company produces its proprietary line of cannabidiol (CBD) based products and distributes products through company owned and franchised clinics, with wholesale partnerships, online channels and with new retail opportunities nationwide in the U.S. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies.

About EuroLife Brands Inc.

EuroLife Brands (CSE: EURO) (FSE: 3CMA) (OTCPK: EURPF) is a leading global markets cannabis brand empowering the medical, recreational and CPG cannabis industry worldwide through a data-driven CBD marketplace supported by exclusive and unbiased physician-backed cannabis education and detailed consumer analytics.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Steven McAuley
CEO
[email protected]
604-789-2146

Investors: Dustin Klein
SVP, Business Development
[email protected]
720-352-1398

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE: Empower Clinics Inc.

Tags: , , , , , , ,
Posted in Empower Clinics Inc. | Comments Off on Empower $CBDT.ca Signs Multi-Year Multi-National Licensing Deal with EuroLife $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Empower Clinics $CBDT.ca Subsidiary Sun Valley Health to Lead Sponsor the Arizona #Cannabis Expo and Empower Board Member Andrejs Bunkse to Speak at Cannabis Industry Event in Phoenix Arizona $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 11:53 AM on Wednesday, February 12th, 2020
  • Announced that its Sun Valley Health division will be a lead sponsor at the Arizona Cannabis Industrial Market Place expo February 13th & 14th, 2020 at the Phoenix Convention Center.
  • In addition, the Company will run an onsite Sun Valley Health POP-UP medical clinic, offering cannabis consultations, certifications and services by Sun Valley Health doctors.

EMPOWER CLINICS SUBSIDIARY SUN VALLEY HEALTH TO LEAD SPONSOR THE ARIZONA CANNABIS EXPO AND EMPOWER BOARD MEMBER ANDREJS BUNKSE TO SPEAK AT CANNABIS INDUSTRY EVENT IN PHOENIX ARIZONA

VANCOUVER B.C. FEBRUARY 12TH, 2020 – EMPOWER CLINICS INC. (CSE: CBDT) (OTC: EPWCF) (Frankfurt 8EC) (“Empower” or the “Company”), a vertically integrated and growth-oriented CBD life sciences company is pleased to announce that its Sun Valley Health division will be a lead sponsor at the Arizona Cannabis Industrial Market Place expo February 13th & 14th, 2020 at the Phoenix Convention Center. In addition, the Company will run an onsite Sun Valley Health POP-UP medical clinic, offering cannabis consultations, certifications and services by Sun Valley Health doctors.

“Our Sun Valley Franchising team has toured the U.S. over the past six months sharing our Scientific Approach to Alternative Medicine.” Said Dustin Klein, SVP Business Development and Director. “Being the title sponsor for the Cannabis Industrial Market Place national tour has brought us tremendous opportunities from around the globe. The upcoming Arizona CIMP Expo gives us the opportunity to share our growth and recent success with our dedicated community of patients, advocates, and business partners.”

The Company is also pleased to announce that Andrejs Bunkse, a Company Director, will be participating as an expert panelist in the “Growing Your Business in the Cannabis Industry” – Fireside Chat hosted by Rebel Rock Accounting of Phoenix Arizona.

https://www.eventbrite.com/e/growing-your-business-in-the-cannabis-industry-fireside-chat-registration-89899753583

“Being an active participant in our industry is imperative to our growth, it provides us greater connections to patients, plus early access to trends and new developments that allow us to be progressive thought leaders” Said Steven McAuley, Chairman & CEO.  

“We are delighted to host this event, bringing together many of Arizona’s successful cannabis operators “ Said Melissa Diaz, CFO & Co-Founder of Rebel Rock. “Our women owned business is at the forefront in helping the cannabis industry become more mainstream and appealing to women consumers and entrepreneurs.” 

ABOUT EMPOWER

Empower is a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company produces its proprietary line of cannabidiol (CBD) based products and distributes products through company owned and franchised clinics, with wholesale partnerships, online channels and with new retail opportunities nationwide in the U.S. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies.

ABOUT REBEL ROCK

Rebel Rock was founded in 2019 by three accomplished female entrepreneurs to fill a clear and vast void in the cannabis industry. Rebel Rock puts confidence in cannabis, by helping emerging cannabis companies manage all their accounting, tax and operational efficiency needs.   The Company offers customized cloud accounting solutions and business system implementations that provide peace of mind, streamlined operations and improved profitability.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors:      Steven McAuley

                   CEO

                   [email protected]

                   604-789-2146

Investors:      Dustin Klein
SVP, Business Development
[email protected]
720-352-1398

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

Tags: , , , , , , , ,
Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca Subsidiary Sun Valley Health to Lead Sponsor the Arizona #Cannabis Expo and Empower Board Member Andrejs Bunkse to Speak at Cannabis Industry Event in Phoenix Arizona $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

« Older Entries
Newer Entries »